May 2026
đź“Ł VC round data is live. Check it out!
Largest DeepTech Public Companies in Australia
Benchmark revenue and EBITDA valuation multiples for public comps like
Cochlear, Droneshield, Imdex, Silex Systems and Weebit Nano.
 | Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment. | $69 | -64% | $5B | $5B | 2.7x | 10.3x | ||
| Droneshield Ltd develops and sells hardware and software for drone detection and security. The principal activity of the company is the development, commercialization, and sales of hardware and software technology for drone detection and security. It has four products: Dismounted, which include RfPatrol Mk2, DroneGun Mk4, Immediate Response Kit (IRK), DroneGun Tactical; On-The-Move includes DroneSentry-X Mk2, Expeditionary Fixed Site (EFS) Kit; Fixed Site includes DroneSentry; and Software includes DroneSentry-C2, Tactical DroneSentry-C2, and DroneOptID. The company provides its solutions to the intelligence community, Government, law enforcement, critical infrastructure, and airports globally. Its geographical segments are the United States and Australia. | $2 | +140% | $2B | $2B | 12.4x | 178.1x | ||
| Imdex Ltd is an Australia-based mining technology company. Its product offering includes an integrated range of drilling optimisation products, cloud-connected rock knowledge sensors, and data and analytical software. Its combined product offering is commodity-agnostic and can be applied across the mining value chain. The company's products and services portfolio comprises solids removal units, directional drilling solutions, drilling fluids, multi-sensor downhole data acquisition, analysis, and visualisation systems, and various software and other mining technology solutions. Geographically, the company generates maximum revenue from the Americas, followed by Asia-Pacific, and Middle East, Africa and Europe. | $3 | +48% | $2B | $2B | 5.2x | 17.2x | ||
| Silex Systems Ltd is an Australian research and development company. The company focused on the development of the SILEX laser uranium enrichment technology as the next-generation technology for the uranium enrichment industry. The company's operating segment includes Silex Systems; Silex USA, and Translucent. It generates maximum revenue from the Silex Systems segment. | $4 | +72% | $1B | $1B | 136.3x | (62.8x) | ||
| Weebit Nano Ltd is a developer and licensor of semiconductor memory technology. The company’s Resistive RAM (ReRAM) addresses the growing need for significantly higher performance and lower power memory solutions in a range of new electronic products such as Internet of Things (IoT) devices, smartphones, robotics, autonomous vehicles, 5G communications and artificial intelligence. Weebit ReRAM is designed to enable semiconductor memory elements to be significantly faster, less expensive, more reliable and more energy efficient than those using existing flash memory solutions. | $5 | +297% | $1B | $1B | 360.1x | (43.2x) | ||
| Elsight Ltd development and commercialisation of the Halo platform for mission-critical applications across defence, homeland security (HLS), and uncrewed systems markets. Provides proprietary software and hardware technology solutions enabling reliable connection confidence for unmanned aerial and ground systems, including drones, robots, and other uncrewed systems. Products include Halo for the Military, Halo for HLS/Public Safety, Halo for Commercial Use, AllSight Management Platform, and HeatSight. Serves Agriculture, Construction and Surveying, Firefighting, First Responders, Mining, Military & Defense, Oil & Gas, Electric & Water Utilities, and Deliveries. Operates in Europe with maximum revenue, Israel, United States of America, and Other foreign countries. | $4 | +670% | $926M | $867M | 38.0x | 111.1x | ||
| Catapult is a technology company that provides analytics solutions to the global sports industry. It is the world’s largest sports technology company for professional sports teams and helps over 5,000 teams in over 40 different sports to gain a competitive edge through athlete monitoring, video analysis, and athlete lifecycle management. | $2 | -42% | $736M | $735M | 6.3x | 41.7x | ||
| Alpha HPA Ltd is an Australian metals and technology company. It is engaged in producing ultra-high purity alumina (HPA) and related aluminium materials through its proprietary solvent extraction (SX) and refining technology. The group's product offerings include a range of ultra-high purity aluminium oxides, hydroxides, and nitrates suitable for various high technology industries, including technical ceramics, LED lighting, synthetic sapphire, semiconductors, specialty catalysts, Direct Lithium Extraction (DLE) technology, and lithium-ion battery markets, among others. It has two reportable segments being the development of the HPA First Project, which generates maximum revenue, and the Alpha Sapphire Project. | $1 | -23% | $727M | $697M | 3066.0x | (33.7x) | ||
| Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region. | $2 | -30% | $661M | $551M | 3.9x | 24.2x | ||
| Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita’s RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months. | $1 | -2% | $628M | $620M | 6.8x | 82.9x | ||
| Racura Oncology Ltdis a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care. Racura's primary asset, RCDS1 (E,E-bisantrene), is a small molecule anticancer agent that functions by binding to G4-DNA and RNA, resulting to potent inhibition of the important cancer growth regulator MYC. RCDS1 has demonstrated therapeutic activity in cancer patients with a well characterised safety profile. Recent researchs made by the company have enabled composition of matter IP filings that provide for 20 years of patent protection over RCDS1. Racura is advancing a proprietary formulation of RCDS1 (RC220) to address the high unmet needs of patients across multiple oncology indications. | $2 | +102% | $333M | $318M | — | — | ||
| Seeing Machines Ltd develops, sells, and licenses products and technology to detect and manage driver fatigue and distraction, partnering for product development, manufacturing, and sales in key markets. It operates two segments: the OEM segment, covering automotive and aviation business units that generate license-based royalties and non-recurring engineering services via Tier 1 customers; and the Aftermarket segment, comprising Fleet and Off-Road units that retrofit technology into commercial vehicles through direct and indirect customers. The Company operates in Australia, North America, Asia-Pacific (excluding Australia), Europe, and other regions, with the majority of revenue coming from Europe. | $0 | +97% | $314M | $368M | 5.9x | (73.9x) | ||
| Australian Strategic Materials Ltd is engaged in the business of producing and mining specialty metal and oxides. The product portfolio includes neodymium, praseodymium, zirconium, hafnium, dysprosium, terbium and niobium oxides. Its Dubbo Project includes Central Western New South Wales, Australia. The company's segment includes Corporate, Dubbo, and Korea. The company generates majority of its revenue from Korea, which includes the Korean Metals Plant. | $1 | +181% | $282M | $235M | 103.5x | (15.9x) | ||
| BrainChip Holdings Ltd is engaged in the development of its Akida Neuromorphic Processor to provide a complete ultra-low power and fast AI Edge Network for vision, audio, olfactory, and smart transducer applications. Its products are Akida IP, Akida 2nd Generation, MetaTF, Akida1000 Ref SoC, and Akida Enablement Platforms. It operates through one segment namely, the technological development of designs. | $0 | -26% | $256M | $225M | 119.2x | (11.4x) | ||
| Metal Powder Works Ltd is focused on producing high-quality metal powders for additive manufacturing. The company is engaged in two segments -Welding Technology in which there is development and commercialisation of proprietary high-speed precision welding solutions that improve the economics of fabrication and second is Metal Powders which includes Manufacture and supply of high-quality metal powders and related technologies for advanced manufacturing, additive manufacturing (3D printing), and other industrial applications. | $2 | +142% | $225M | $215M | 187.4x | (88.9x) | ||
| Appen Ltd is engaged in the provision of quality data solutions and services for machine learning and artificial intelligence applications for technology companies, auto manufacturers, government agencies among others. The company's business segments are Appen Global and Appen China. It generates maximum revenue from the Appen Global segment which represents all operations outside of the China Group. The Appen China segment represents the China Group operations and includes Japan and Korea. Geographically, it derives a majority of its revenue from the United States of America, and has its presence in China, Australia and Others. | $1 | -1% | $223M | $172M | 0.7x | 13.6x | ||
| Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir, which is a collagen wrap used in peripheral nerve repair; and OrthoACI, an implant used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline, such as Tendon Cell Therapy and Collagen Medical Device Platform. | $1 | -34% | $156M | $124M | 20.6x | (23.7x) | ||
| Zeotech Ltd is an industrial kaolin and mineral processing technology company focused on developing the Toondoon and Abercorn Projects in central Queensland, Australia. Toondoon is a high-grade kaolin deposit with approved mining leases and infrastructure access, while Abercorn hosts a notable kaolin resource for long-term development. The company produces AusPozz, a high-reactivity metakaolin for low-carbon cement, and develops proprietary zeolite technologies for methane emissions control. Supported by research collaborations, Zeotech addresses challenges in reducing construction carbon and greenhouse gas emissions. It operates in exploration, evaluation, and commercialisation within Australia. | $0 | 0% | $121M | $112M | — | — | ||
| EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury. | $1 | +2% | $115M | $105M | — | — | ||
| Talga Group Ltd is a technology minerals company. The Group operates in three operating segments being graphite exploration, graphite development; and research and development in four geographical locations, being graphite exploration and development in Sweden, graphite or graphene research and development in Germany and research and development in the United Kingdom, with Australia as unallocated corporate. The graphite projects include Vittangi Anode Project. It derives a majority of revenue from the United Kingdom. | $0 | -25% | $106M | $86M | 1135.2x | (7.9x) | ||
| Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States. | $0 | -26% | $82M | $71M | 103.6x | (16.9x) | ||
| PlaySide Studios Ltd is a video game developer in Australia. The company delivers games across four platforms: Mobile, Virtual Reality (VR), Augmented Reality (AR), and PC. Some of its games include Ghost Pop, Flush Force, Defend the Bits, Dumb Ways to Dash, and many others. The company has one reportable segment, the development and monetization of mobile, PC, and console video games. | $0 | +60% | $75M | $65M | 1.9x | (13.7x) | ||
| AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP. | $0 | +303% | $68M | $68M | 98.4x | (18.5x) | ||
| Cyclopharm Ltd is a company that engages in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It operates through the following segments. The Technegas segment involves supplying diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism, and distributor of products to the diagnostic imaging sector. The Molecular Imaging segment offers to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders, and cardiac disease. The firm generates maximum revenue from the Technegas segment. | $1 | -40% | $64M | $65M | 2.8x | (5.7x) | ||
| Archer Materials Ltd is a technology company with a focus on developing deep tech in the semiconductor industry. The group is developing and working towards commercialising semiconductor devices and sensors relevant to quantum computing, TMR sensors and lab-on-a-chip medical diagnostics. It engages in technology research and development of the carbon nano onion quantum material (12CQ Project), TMR sensor project and graphene-based lab-on-a-chip biosensing chip; utilising semiconductor development infrastructure and facilities, R&D, people, and IP, to support technology research and development. | $0 | +14% | $62M | $55M | — | — | ||
| Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions. | $0 | -- | $31M | $24M | 2.2x | (3.2x) | ||
| Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world. | $0 | -68% | $19M | $19M | 0.9x | (83.1x) | ||
| EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand. | $0 | -65% | $18M | $9M | 0.2x | 1.1x | ||
| Pointerra Ltd provides cloud technology services. It is focused on the international commercialization of its proprietary digital twin technology solution to support digital asset management activities across a range of sectors, including utilities, defense and intelligence, survey and mapping, mining, oil & gas, architecture, engineering, construction, operations, and transport. Pointerra’s cloud-based solution is built on AI-driven compression, visualisation, and analytics algorithms that index massive 3D datasets. | $0 | -45% | $18M | $16M | 2.3x | (36.1x) | ||
| 4DS Memory Ltd is a semiconductor company which is in the research and development of a non-volatile memory technology known as Interface Switching ReRAM, for next-generation gigabyte Storage Class Memory. Facilities located in Silicon Valley. | $0 | -79% | $16M | $10M | 14043620.0x | (2.2x) | ||
| Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate. | $0 | -- | $4M | $4M | 0.7x | (0.5x) | ||
| Median | $1 | -1% | $223M | $172M | 6.8x | (7.9x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.